Advanced Search

Notes from the Field: Whole-Genome Sequences Analysis Displays Relationship of SARS-CoV-2 Delta Variant Between Four Local Cases and Passengers of a Flight from South Africa — Shenzhen City, Guangdong Province, China, June 2021

View author affiliations
  • loading...
  • Funding:Shenzhen Science and Technology Innovation Commission Key project (no. JSGG20200225152648408), the Shenzhen Science and Technology Innovation Commission COVID-19 Special Fund (no. JSGG20200207161926465), and Sanming Project of Medicine in Shenzhen (No.SZSM202011008)
  • [1] Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018;35(6):1547 − 9. http://dx.doi.org/10.1093/molbev/msy096.
    [2] Li ZC, Nie K, Li KB, Hu Y, Song Y, Kang M, et al. Genome characterization of the first outbreak of COVID-19 delta variant B. 1. 617. 2 — Guangzhou City, Guangdong Province, China, May. China CDC Wkly 2021(27):587 − 9. http://dx.doi.org/10.46234/ccdcw2021.151.
    [3] European Centre for Disease Prevention and Control. Implications for the EU/EEA on the spread of the SARSCoV-2 delta (B. 1.617. 2) variant of concern - 23 June 2021. ECDC: Stockholm. 2021.https://www.ecdc.europa.eu/sites/default/files/documents/Implications-for-the-EU-EEA-on-the-spread-of-SARS-CoV-2-Delta-VOC-23-June-2021_2.pdf.[2021–08–14].
    [4] Campbell F, Archer B, Laurenson-Schafer H, Jinnai Y, Konings F, Batra N, et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill 2021;26(24):2100509. http://dx.doi.org/10.2807/1560-7917.ES.2021.26.24.2100509.
    [5] Scientific Advisory Group for Emergencies. SPI-M-O: consensus statement on COVID-19, 3 June 2021. GOV. UK. 2021.https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-3-june-2021.[2021-08-14].
    [6] Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 2021;596(7871):276 − 280. http://dx.doi.org/10.1038/s41586-021-03777-9.
    [7] Liu C, Ginn HM, Dejnirattisai W, Supasa P, Wang BB, Tuekprakhon A, et al. Reduced neutralization of SARS-CoV-2 B. 1. 617 by vaccine and convalescent serum. Cell 2021;184(16):4220 − 36.e13. http://dx.doi.org/10.1016/j.cell.2021.06.020.
  • FIGURE 1.Evolutionary relationships of 30 SARS-CoV-2 strains of lineage B.1.617.2 from this study.

    Note: Maximum likelihood phylogenetic tree was reconstructed for 30 SARS-CoV-2 strains from this study and 16 reference strains based on the whole-genome sequences. The best fit nucleotide substitution model used for phylogenetic reconstruction was TN93+G5+I. The scale bar represents a genetic distance of 0.0002 nucleotide substitutions per site. Bootstrap analysis (1,000 replicates) was used for statistical support of the tree. The 4 local strains were indicated by red dots, and 26 imported strains were indicated by black dots.

    TABLE 1.Nucleotide differences between 30 SARS-CoV-2 strains of lineage B.1.617.2 from this study and the reference strain Wuhan-Hu-1 (NC_045512.2).

    Clade Case Nucleotide variation Nucleotide deletion mutation
    Clade A Case 1 G210T, C241T, C799T, C3037T, G4181T, C6402T, C7124T, C8986T, G9053T, C10029T, A11201G, A11332G, G13812T, C14408T, G15451A, C16466T, C19220T, C21618G, G21987A, T22917G, C22995A, A23403G, C23604G, G24410A, C25413T, C25469T, T26767C, T27638C, C27752T, C27874T, A28461G, G28881T, G28916T, G29402T, and G29742T del22029-22034,
    del28248-28253,
    del28271
    Clade B Case A, Case 2, Case 5–9, Case 11–15, Case 18,
    Case 19, Case 21,
    Case 30–32, Case 36,
    Case 38
    31 variation sites: G210T, C241T, G410T, C3037T, C5184T, A5584G, T9429C, C9891T, T11418C, C11514T, C13019T, C14408T, G15451A, C16466T, C21618G, G21987A, C22227T, T22917G, C22995A, A23403G, C23604G, G24410A, C25469T, T26767C, T27638C, A27677C, C27752T, A28461G, G28881T, G29402T, and G29742T del510-518, del22029-22034, del28248-28253, del28271
    Case B, Case 20 31 variation sites+C21575T del510-518, del22029-22034, del28248-28253, del28271
    Case C 31 variation sites+C18431T del510-518, del22029-22034, del28249, del28253, del28271
    Case D 31 variation sites+C10605A del510-518, del22029-22034, del28248-28253, del28271
    Case 4 31 mutations -G210T-G410T-G21987A0 -
    C22227T+G174T+C1059T+A5839G
    del28249, del28253, del28271
    Case 10 31 mutations+C11665T del510-518, del22029-22034, del28248-28253, del28271
    Case 34, Case 39 31 mutations+G3875A+G6476T del510-518, del22029-22034, del28248-28253, del28271
    Case 37 31 mutations+A28249T+C28253A del510-518, del22029-22034, del28271
    Download: CSV

    TABLE S1.Demographic characteristics of 4 local cases and 39 imported cases, and specimen testing information.

    Case Gender Age (years) Date of first positive detection
    of COVID-19 virus
    Ct value (ORF1ab/N) of specimen used for sequencing
    Daan Bojie
    Case A Male 30 June 14, 2021 14/18 16/18
    Case B Female 21 June 17, 2021 23/21 22/22
    Case C Male 35 June 18, 2021 24/22 22/24
    Case D Female 64 June 20, 2021 30/30 35/28
    Case 1 Male 36 June 11, 2021 31/31 30/31
    Case 2 Male 35 June 11, 2021 31/31 26/28
    Case 3 Female 42 June 11, 2021 33/34 34/34
    Case 4 Female 58 June 11, 2021 30/27 27/28
    Case 5 Male 53 June 13, 2021 17/16 16/17
    Case 6 Male 32 June 14, 2021 24/23 24/23
    Case 7 Male 52 June 14, 2021 17/17 16/17
    Case 8 Male 33 June 15, 2021 17/15 15/17
    Case 9 Male 47 June 15, 2021 16/16 15/16
    Case 10 Male 64 June 15, 2021 21/20 20/21
    Case 11 Male 40 June 15, 2021 15/14 14/15
    Case 12 Male 50 June 15, 2021 18/17 16/18
    Case 13 Male 33 June 15, 2021 28/26 27/28
    Case 14 Female 31 June 15, 2021 19/17 18/17
    Case 15 Male 61 June 15, 2021 14/14 15/15
    Case 16 Female 38 June 15, 2021 35/34 36/33
    Case 17 Male 39 June 15, 2021 37/40 Undet/35
    Case 18 Female 50 June 15,2021 14/15 14/14
    Case 19 Male 35 June 15, 2021 17/16 16/17
    Case 20 Male 58 June 15, 2021 16/15 15/16
    Case 21 Female 47 June 15, 2021 29/25 26/26
    Case 22 Male 29 June 15, 2021 35/35 38/Undet
    Case 23 Male 32 June 15, 2021 38/36 Undet/35
    Case 24 Male 63 June 15, 2021 35/34 35/32
    Case 25 Female 63 June 15, 2021 35/33 33/33
    Case 26 Male 45 June 15, 2021 38/35 Undet/Undet
    Case 27 Male 44 June 15, 2021 Undet/38 Undet/35
    Case 28 Male 61 June 15, 2021 Undet/37 37/Undet
    Case 29 Male 58 June 15, 2021 37/Undet Undet/36
    Case 30 Male 9 June 15, 2021 21/21 22/22
    Case 31 Female 45 June 15, 2021 28/28 27/28
    Case 32 Male 42 June 15, 2021 15/15 14/15
    Case 33 Male 35 June 16, 2021 26/24 23/26
    Case 34 Male 1 June 16, 2021 30/27 27/29
    Case 35 Female 24 June 17, 2021 34/30 32/30
    Case 36 Male 25 June 17, 2021 19/18 19/18
    Case 37 Female 32 June 19, 2021 22/19 19/20
    Case 38 Male 38 June 19, 2021 31/29 28/30
    Case 39 Female 28 June 25, 2021 18/16 17/18
    Note: There were 43 subjects in total, and the male/female ratio and mean age of subjects was 2.58∶1 and 40.9 years, respectively.
    Abbreviations: Undet=Undetected; Ct=Cycle threshold; COVID-19=Coronavirus disease 2019.
    Download: CSV

    TABLE S2.Genome sequence information for 30 SARS-CoV-2 strains of lineage B.1.617.2 from this study.

    Case Virus name Length in nt
    (% GC content)
    Closest strain by an audacity instant
    search in GISAID
    Case A hCoV-19/Shenzhen/IVDC-06-14/2021 29,813nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case B hCoV-19/Shenzhen/IVDC-06-17/2021 29,562nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case C hCoV-19/Shenzhen/IVDC-06-18/2021 29,428nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case D hCoV-19/Shenzhen/IVDC-06-20/2021 29,612nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case 1 hCoV-19/Shenzhen/IVDC-0610-01/2021 29,702nt (37.96) hCoV-19/India/GJ-NCDC-NIV-INSACOG-24095/2021
    Case 2 hCoV-19/Shenzhen/IVDC-0610-02/2021 29,813nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 4 hCoV-19/Shenzhen/IVDC-0610-04/2021 29,836nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 5 hCoV-19/Shenzhen/IVDC-0610-05/2021 29,555nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 6 hCoV-19/Shenzhen/IVDC-0610-06/2021 29,657nt (38.00) hCoV-19/England/MILK-155F811/2021
    Case 7 hCoV-19/Shenzhen/IVDC-0610-07/2021 29,814nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 8 hCoV-19/Shenzhen/IVDC-0610-08/2021 29,824nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 9 hCoV-19/Shenzhen/IVDC-0610-09/2021 29,831nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 10 hCoV-19/Shenzhen/IVDC-0610-10/2021 29,833nt (37.95) hCoV-19/England/MILK-155F811/2021
    Case 11 hCoV-19/Shenzhen/IVDC-0610-11/2021 29,830nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 12 hCoV-19/Shenzhen/IVDC-0610-12/2021 29,830nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 13 hCoV-19/Shenzhen/IVDC-0610-13/2021 29,710nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 14 hCoV-19/Shenzhen/IVDC-0610-14/2021 29,551nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case 15 hCoV-19/Shenzhen/IVDC-0610-15/2021 29,834nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 18 hCoV-19/Shenzhen/IVDC-0610-18/2021 29,820nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 19 hCoV-19/Shenzhen/IVDC-0610-19/2021 29,828nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 20 hCoV-19/Shenzhen/IVDC-0610-20/2021 29,820nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 21 hCoV-19/Shenzhen/IVDC-0610-21/2021 29,574nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 30 hCoV-19/Shenzhen/IVDC-0610-30/2021 29,827nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 31 hCoV-19/Shenzhen/IVDC-0610-31/2021 29,829nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 32 hCoV-19/Shenzhen/IVDC-0610-32/2021 29,849nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 34 hCoV-19/Shenzhen/IVDC-0610-34/2021 29,809nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 36 hCoV-19/Shenzhen/IVDC-0610-36/2021 29,819nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 37 hCoV-19/Shenzhen/IVDC-0610-37/2021 29,827nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 38 hCoV-19/Shenzhen/IVDC-0610-38/2021 29,553nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 39 hCoV-19/Shenzhen/IVDC-0610-39/2021 29,797nt (37.94) hCoV-19/England/MILK-155F811/2021
    Abbreviation: nt=Nucleotide.
    Download: CSV

Citation:

通讯作者:陈斌, bchen63@163.com
  • 1.

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Turn off MathJax
Article Contents

Article Metrics

Article views(14632) PDF downloads(49)Cited by()

Share

Related

Whole-Genome Sequences Analysis Displays Relationship of SARS-CoV-2 Delta Variant Between Four Local Cases and Passengers of a Flight from South Africa — Shenzhen City, Guangdong Province, China, June 2021

View author affiliations
  • 1. Institute of Pathogen Biology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China
  • 2. Shenzhen Center for Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China
  • 3. Department of Communicable Diseases Control and Prevention, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China
  • 4. Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China
  • 5. Laboratory of Molecular Epidemiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China
  • Corresponding authors:

    Long Chen,chen_l_2011@163.com ;

    Tiejian Feng,fengtiej@126.com ;

    Xuan Zou,914494557@qq.com

  • Funding:Shenzhen Science and Technology Innovation Commission Key project (no. JSGG20200225152648408), the Shenzhen Science and Technology Innovation Commission COVID-19 Special Fund (no. JSGG20200207161926465), and Sanming Project of Medicine in Shenzhen (No.SZSM202011008)
  • Online Date:October 12 2021
    Issue Date:December 10 2021
    doi:10.46234/ccdcw2021.215
  • On June 14, 2021, a customs officer (Case A) went to the infirmary at Baoan International Airport in Shenzhen due to a runny nose and fever. He was admitted to the Central Hospital of Baoan immediately. This patient preliminarily tested positive for coronavirus disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using a quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) method in this hospital. Then, a mixed specimen of nasopharyngeal swab, oropharyngeal swab, and anal swab was sent to the virology laboratory of Shenzhen Center for Disease Control and Prevention (Shenzhen CDC) and was confirmed positive for SARS-CoV-2 by a qRT-PCR method simultaneously implemented in two commercial kits (Daan, Guangzhou, China and Bojie, Shanghai, China) (Supplementary Table S1). This patient tested negative for SARS-CoV-2 on June 8, 2021 and participated in an epidemiological investigation and sampling in a flight from South Africa that arrived at Baoan International Airport on June 10, 2021. Between June 10, 2021 and June 25, 2021, a total of 39 passengers (Case 1 to 39) from this flight were confirmed to be infected with SARS-CoV-2 in the virology laboratory of Shenzhen CDC.

    On June 17, 2021, a third-party laboratory detected SARS-CoV-2 in a mixed specimen of 10 swabs from ten individuals by qRT-PCR method, and the preliminary result was positive. This mixed specimen and one (Case B) of ten nasopharyngeal swabs from ten individuals were confirmed positive for SARS-CoV-2 in the virology laboratory of Shenzhen CDC. Case B was a 22-year-old female who worked in a restaurant at Baoan International Airport. The third case (Case C) lived in Dongguan City and worked in Nanshan District in Shenzhen City. He presented symptoms of chills, dry cough, diarrhea, and fever on June 12, 2021 and was confirmed to be infected with SARS-CoV-2 on June 18, 2021. The fourth case (Case D) lived and worked in Baoan District, Shenzhen. She was confirmed to be infected with SARS-CoV-2 during screening of key populations on June 20, 2021.

    High-throughput sequencing was performed for 4 local SARS-CoV-2 strains and 39 imported SARS-CoV-2 strains by Illumina Sequencing Technology. First, viral RNA was extracted directly from 200-μL swab samples using a High Pure Viral RNA Kit (Roche, Germany). Second, viral RNA was reverse-transcribed and amplified using ULSEN®2019-nCoV Whole Genome Capture Kit V-090418 (Beijing MicroFuture Technology Co., Ltd, Beijing, China). Third, the sequencing libraries were prepared using the Nextera®XT Library Prep Kit FC-131-1001(Illumina, Inc., San Diego, USA). The final viral-enriched libraries were sequenced using the MiSeq platform (Illumina, USA). The viral genome was assembled by MicronCoV®Analyzer M-881027 (Beijing MicroFuture Technology Co., Ltd, Beijing, China). Genome sequences of the 4 local SARS-CoV-2 strains and 28 of 39 imported SARS-CoV-2 strains were successfully determined. Virus strains from this study were genotyped using the online Pangolin COVID-19 Lineage Assigner ( www.pangolin.cog-uk.io/ ). The evolutionary relationship of local SARS-CoV-2 strains and imported SARS-CoV-2 strains was inferred with the program MEGA version Ⅹ ( www.megasoftware.net ) (1). Nucleotide difference between viral genome sequences from this study and the reference sequence Wuhan-Hu-1 (GenBank no. NC_045512.2) was analyzed using the programs BioEdit 7.1.9 ( www.bioedit.software.informer.com ) and MEGA versionⅩ.

    The 4 local SARS-CoV-2 strains and 26 of 28 imported SARS-CoV-2 strains from this study were assigned to lineage B.1.617.2 (Supplementary Table S2), which was the fourth variant of concern (VOC) (Delta variant). The other two imported SARS-CoV-2 strains were assigned to lineage B.1.351 and lineage C.1.2. Molecular phylogeny indicated that 30 SARS-CoV-2 Delta variants (lineage B.1.617.2) from this study formed 2 distinct clades (Figure 1). The imported strain hCoV-19/Shenzhen/IVDC-0610-01/2021 (Case1) clustered in clade A and showed the closest relationship to the Indian strain hCoV-19/India/GJ-NCDC-NIV-INSACOG-24095/2021 by an Audacity Instant search in Global initiative on sharing all influenza data (GISAID). The 4 local SARS-CoV-2 strains of lineage B.1.617.2 and 25 imported SARS-CoV-2 strains of lineage B.1.617.2 clustered in clade B and showed the closest relationship or showed only one nucleotide difference to the British strain hCoV-19/England/MILK-155F811/2021. These 29 SARS-CoV-2 strains of lineage B.1.617.2 showed at least 23 nucleotide differences to the strain hCoV-19/ Shenzhen/IVDC-0610-01/2021 (Case 1). In clade B, the imported strain hCoV-19/Shenzhen/IVDC-0610-04/2021 (Case 4) showed a certain degree of genetic distance to the other 28 virus strains from this study, which was also indicated by comparative analysis of genome sequences inTable 1. The local B.1.617.2 strain hCoV-19/Shenzhen/IVDC-06-14/2021 (Case A) showed 100% sequence identity to 19 imported B.1.617.2 strains (Table 1). These 20 SARS-CoV-2 strains of lineage B.1.617.2 shared 31 nucleotide variation sites and 22 deletion mutations compared with the reference strain Wuhan-Hu-1. Except for the variation sites above, an additional variation site was observed in genomes of the 3 local strains hCoV-19/Shenzhen/IVDC-06-17/2021 (Case B), hCoV-19/Shenzhen/IVDC-06-18/2021 (Case C), and hCoV-19/Shenzhen/IVDC-06-20/2021 (Case D). The local strain hCoV-19/Shenzhen/IVDC-06-17/2021 (Case B) showed 100% sequence identity to the strain hCoV-19/Shenzhen/IVDC-0610-20/2021 from imported Case 20.

    Figure 1.

    Evolutionary relationships of 30 SARS-CoV-2 strains of lineage B.1.617.2 from this study.

    Note: Maximum likelihood phylogenetic tree was reconstructed for 30 SARS-CoV-2 strains from this study and 16 reference strains based on the whole-genome sequences. The best fit nucleotide substitution model used for phylogenetic reconstruction was TN93+G5+I. The scale bar represents a genetic distance of 0.0002 nucleotide substitutions per site. Bootstrap analysis (1,000 replicates) was used for statistical support of the tree. The 4 local strains were indicated by red dots, and 26 imported strains were indicated by black dots.
    Clade Case Nucleotide variation Nucleotide deletion mutation
    Clade A Case 1 G210T, C241T, C799T, C3037T, G4181T, C6402T, C7124T, C8986T, G9053T, C10029T, A11201G, A11332G, G13812T, C14408T, G15451A, C16466T, C19220T, C21618G, G21987A, T22917G, C22995A, A23403G, C23604G, G24410A, C25413T, C25469T, T26767C, T27638C, C27752T, C27874T, A28461G, G28881T, G28916T, G29402T, and G29742T del22029-22034,
    del28248-28253,
    del28271
    Clade B Case A, Case 2, Case 5–9, Case 11–15, Case 18,
    Case 19, Case 21,
    Case 30–32, Case 36,
    Case 38
    31 variation sites: G210T, C241T, G410T, C3037T, C5184T, A5584G, T9429C, C9891T, T11418C, C11514T, C13019T, C14408T, G15451A, C16466T, C21618G, G21987A, C22227T, T22917G, C22995A, A23403G, C23604G, G24410A, C25469T, T26767C, T27638C, A27677C, C27752T, A28461G, G28881T, G29402T, and G29742T del510-518, del22029-22034, del28248-28253, del28271
    Case B, Case 20 31 variation sites+C21575T del510-518, del22029-22034, del28248-28253, del28271
    Case C 31 variation sites+C18431T del510-518, del22029-22034, del28249, del28253, del28271
    Case D 31 variation sites+C10605A del510-518, del22029-22034, del28248-28253, del28271
    Case 4 31 mutations -G210T-G410T-G21987A0 -
    C22227T+G174T+C1059T+A5839G
    del28249, del28253, del28271
    Case 10 31 mutations+C11665T del510-518, del22029-22034, del28248-28253, del28271
    Case 34, Case 39 31 mutations+G3875A+G6476T del510-518, del22029-22034, del28248-28253, del28271
    Case 37 31 mutations+A28249T+C28253A del510-518, del22029-22034, del28271

    Table 1.Nucleotide differences between 30 SARS-CoV-2 strains of lineage B.1.617.2 from this study and the reference strain Wuhan-Hu-1 (NC_045512.2).

    Among imported SARS-CoV-2 strains, genome sequences of 19 SARS-CoV-2 strains from imported passengers showed 100% sequence identity to each other, and these 19 passengers had no common exposure history before boarding. It suggested that at least one virus transmission occurred among the 19 passengers after boarding. The only strain from Case 1 belonged to clade A within lineage B.1.617.2, which indicated that Case 1 was not related to the infection in the cabin. Based on phylogenetic relationship and comparative analysis of genome sequences, we deduced that 3 virus strains from local cases (Cases B to D) and 5 virus strains from imported passengers (Cases 10, 20, 34, 37, and 39) were progeny viruses.

    According to the report by Li et al (2), SARS-CoV-2 Delta variant strains from this study showed 18 to 28 nucleotide differences to those from the first outbreak of COVID-19 in Guangzhou, May 2021, which suggested that the SARS-CoV-2 Delta variant that caused local outbreaks of COVID-19 in Guangzhou and Shenzhen came from different sources. At present, the SARS-CoV-2 Delta variant is becoming the dominant variant worldwide and has been detected in at least 142 countries as of August 10, 2021. The SARS-CoV-2 Delta variant is posing new challenges on the control and prevention of COVID-19 due to its increased transmissibility compared with Alpha variant (lineage B.1.1.7) and capacity of immune escape (3-7).

    In conclusion, whole-genome sequencing (WGS) confirmed that 4 local SARS-CoV-2 strains and 26 of 28 imported SARS-CoV-2 strains from this study were Delta variants, and phylogenetic and comparative genome analyses showed close relationship between the four local SARS-CoV-2 strains of Delta variant and imported SARS-CoV-2 strains of Delta variant introduced from South Africa.

  • Baoan CDC, Nanshan CDC, and Shenzhen Third People’s Hospital.

  • No conflicts of interest.

    Case Gender Age (years) Date of first positive detection
    of COVID-19 virus
    Ct value (ORF1ab/N) of specimen used for sequencing
    Daan Bojie
    Case A Male 30 June 14, 2021 14/18 16/18
    Case B Female 21 June 17, 2021 23/21 22/22
    Case C Male 35 June 18, 2021 24/22 22/24
    Case D Female 64 June 20, 2021 30/30 35/28
    Case 1 Male 36 June 11, 2021 31/31 30/31
    Case 2 Male 35 June 11, 2021 31/31 26/28
    Case 3 Female 42 June 11, 2021 33/34 34/34
    Case 4 Female 58 June 11, 2021 30/27 27/28
    Case 5 Male 53 June 13, 2021 17/16 16/17
    Case 6 Male 32 June 14, 2021 24/23 24/23
    Case 7 Male 52 June 14, 2021 17/17 16/17
    Case 8 Male 33 June 15, 2021 17/15 15/17
    Case 9 Male 47 June 15, 2021 16/16 15/16
    Case 10 Male 64 June 15, 2021 21/20 20/21
    Case 11 Male 40 June 15, 2021 15/14 14/15
    Case 12 Male 50 June 15, 2021 18/17 16/18
    Case 13 Male 33 June 15, 2021 28/26 27/28
    Case 14 Female 31 June 15, 2021 19/17 18/17
    Case 15 Male 61 June 15, 2021 14/14 15/15
    Case 16 Female 38 June 15, 2021 35/34 36/33
    Case 17 Male 39 June 15, 2021 37/40 Undet/35
    Case 18 Female 50 June 15,2021 14/15 14/14
    Case 19 Male 35 June 15, 2021 17/16 16/17
    Case 20 Male 58 June 15, 2021 16/15 15/16
    Case 21 Female 47 June 15, 2021 29/25 26/26
    Case 22 Male 29 June 15, 2021 35/35 38/Undet
    Case 23 Male 32 June 15, 2021 38/36 Undet/35
    Case 24 Male 63 June 15, 2021 35/34 35/32
    Case 25 Female 63 June 15, 2021 35/33 33/33
    Case 26 Male 45 June 15, 2021 38/35 Undet/Undet
    Case 27 Male 44 June 15, 2021 Undet/38 Undet/35
    Case 28 Male 61 June 15, 2021 Undet/37 37/Undet
    Case 29 Male 58 June 15, 2021 37/Undet Undet/36
    Case 30 Male 9 June 15, 2021 21/21 22/22
    Case 31 Female 45 June 15, 2021 28/28 27/28
    Case 32 Male 42 June 15, 2021 15/15 14/15
    Case 33 Male 35 June 16, 2021 26/24 23/26
    Case 34 Male 1 June 16, 2021 30/27 27/29
    Case 35 Female 24 June 17, 2021 34/30 32/30
    Case 36 Male 25 June 17, 2021 19/18 19/18
    Case 37 Female 32 June 19, 2021 22/19 19/20
    Case 38 Male 38 June 19, 2021 31/29 28/30
    Case 39 Female 28 June 25, 2021 18/16 17/18
    Note: There were 43 subjects in total, and the male/female ratio and mean age of subjects was 2.58∶1 and 40.9 years, respectively.
    Abbreviations: Undet=Undetected; Ct=Cycle threshold; COVID-19=Coronavirus disease 2019.

    Table S1.Demographic characteristics of 4 local cases and 39 imported cases, and specimen testing information.

    Case Virus name Length in nt
    (% GC content)
    Closest strain by an audacity instant
    search in GISAID
    Case A hCoV-19/Shenzhen/IVDC-06-14/2021 29,813nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case B hCoV-19/Shenzhen/IVDC-06-17/2021 29,562nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case C hCoV-19/Shenzhen/IVDC-06-18/2021 29,428nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case D hCoV-19/Shenzhen/IVDC-06-20/2021 29,612nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case 1 hCoV-19/Shenzhen/IVDC-0610-01/2021 29,702nt (37.96) hCoV-19/India/GJ-NCDC-NIV-INSACOG-24095/2021
    Case 2 hCoV-19/Shenzhen/IVDC-0610-02/2021 29,813nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 4 hCoV-19/Shenzhen/IVDC-0610-04/2021 29,836nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 5 hCoV-19/Shenzhen/IVDC-0610-05/2021 29,555nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 6 hCoV-19/Shenzhen/IVDC-0610-06/2021 29,657nt (38.00) hCoV-19/England/MILK-155F811/2021
    Case 7 hCoV-19/Shenzhen/IVDC-0610-07/2021 29,814nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 8 hCoV-19/Shenzhen/IVDC-0610-08/2021 29,824nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 9 hCoV-19/Shenzhen/IVDC-0610-09/2021 29,831nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 10 hCoV-19/Shenzhen/IVDC-0610-10/2021 29,833nt (37.95) hCoV-19/England/MILK-155F811/2021
    Case 11 hCoV-19/Shenzhen/IVDC-0610-11/2021 29,830nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 12 hCoV-19/Shenzhen/IVDC-0610-12/2021 29,830nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 13 hCoV-19/Shenzhen/IVDC-0610-13/2021 29,710nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 14 hCoV-19/Shenzhen/IVDC-0610-14/2021 29,551nt (37.98) hCoV-19/England/MILK-155F811/2021
    Case 15 hCoV-19/Shenzhen/IVDC-0610-15/2021 29,834nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 18 hCoV-19/Shenzhen/IVDC-0610-18/2021 29,820nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 19 hCoV-19/Shenzhen/IVDC-0610-19/2021 29,828nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 20 hCoV-19/Shenzhen/IVDC-0610-20/2021 29,820nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 21 hCoV-19/Shenzhen/IVDC-0610-21/2021 29,574nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 30 hCoV-19/Shenzhen/IVDC-0610-30/2021 29,827nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 31 hCoV-19/Shenzhen/IVDC-0610-31/2021 29,829nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 32 hCoV-19/Shenzhen/IVDC-0610-32/2021 29,849nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 34 hCoV-19/Shenzhen/IVDC-0610-34/2021 29,809nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 36 hCoV-19/Shenzhen/IVDC-0610-36/2021 29,819nt (37.96) hCoV-19/England/MILK-155F811/2021
    Case 37 hCoV-19/Shenzhen/IVDC-0610-37/2021 29,827nt (37.97) hCoV-19/England/MILK-155F811/2021
    Case 38 hCoV-19/Shenzhen/IVDC-0610-38/2021 29,553nt (37.99) hCoV-19/England/MILK-155F811/2021
    Case 39 hCoV-19/Shenzhen/IVDC-0610-39/2021 29,797nt (37.94) hCoV-19/England/MILK-155F811/2021
    Abbreviation: nt=Nucleotide.

    Table S2.Genome sequence information for 30 SARS-CoV-2 strains of lineage B.1.617.2 from this study.

Reference (7)

Citation:

Catalog

    /

    Return
    Return
      Baidu
      map